Citius Oncology Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Citius Oncology Inc
CIK #0001851484
EDGAR Form CIK 2011 - 2026
10-K [0001851484]
10-Q [0001851484]
3 [0001851484]
4 [0001851484]
8-K [0001851484]
SC 13D [0001851484]
SC 13G [0001851484]
Form 13D/13G Filer Form 13D/13G Subject Filed
Armistice Capital LLC Citius Oncology Inc [2025-11-14]
Citius Pharmaceuticals Inc Citius Oncology Inc [2024-08-16]
Mizuho Financial Group Inc TENX Keane Acquisition [2024-02-13]
Karpus Management Inc TENX Keane Acquisition [2024-02-13]
Wolverine Asset Management LLC TENX Keane Acquisition [2024-02-08]
Hudson Bay Capital Management LP TENX Keane Acquisition [2023-02-10]
10XYZ Holdings LP TENX Keane Acquisition [2022-10-28]
FEIS Lawrence TENX Keane Acquisition [2022-10-20]
Space Summit Capital LLC TENX Keane Acquisition [2022-10-19]
Form 3/4/5 Subject 2011 - 2026
Citius Oncology Inc
Mayersohn Joel David
Czuczman Myron
Mazur Leonard L
Bartushak Jaime
McGrath Dennis M
Dutia Suren G
Holuka Eugene Myron
Webb Carol
Smith Robert Joseph
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Citius Oncology Inc CTOR
Common Stock
2025-07-28 Other 21,228 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 400,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 125,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 125,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 125,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 125,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 300,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 50,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 125,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 250,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 400,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-12-12 Grant 800,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-08-12 Grant 466,667 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-08-12 Grant 1,233,333 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-08-12 Grant 466,667 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-08-12 Grant 500,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-08-12 Grant 150,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-08-12 Grant 150,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-08-12 Grant 150,000 $0.00
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
2024-08-12 Grant 150,000 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com